Michelle Green

About

Work

qPharmetra

Principal Consultant

Apr 2021

→

Present

Certara

Executive Director

Apr 2021

Publications

Modeling of Proliferating CD4 and CD8 T‐Cell Changes to Tremelimumab Exposure in Patients with Unresectable Hepatocellular Carcinoma

Jan 2023

Published by

Clinical Pharmacology & Therapeutics

Summary

journal-article

Population pharmacokinetics of rucaparib in patients with advanced ovarian cancer or other solid tumors

Jan 2022

Published by

Cancer Chemotherapy and Pharmacology

Summary

journal-article

Model-informed drug development of voxelotor in sickle cell disease: Exposure-response analysis to support dosing and confirm mechanism of action.

Jan 2022

Published by

CPT: pharmacometrics & systems pharmacology

Summary

journal-article

Model-informed drug development of voxelotor in sickle cell disease: Population pharmacokinetics in whole blood and plasma.

Jan 2022

Published by

CPT: pharmacometrics & systems pharmacology

Summary

journal-article

Effect of Anti-VEGF Therapy on the Disease Progression of Neovascular Age-Related Macular Degeneration: A Systematic Review and Model-Based Meta-Analysis.

Jan 2022

Published by

Journal of clinical pharmacology

Summary

journal-article

Population exposure-efficacy and exposure-safety analyses for rucaparib in patients with recurrent ovarian carcinoma from Study 10 and ARIEL2.

Jan 2021

Published by

Gynecologic oncology

Summary

journal-article

Model-Informed Drug Development of the Masked Anti-PD-L1 Antibody CX-072.

Jan 2020

Published by

Clinical pharmacology and therapeutics

Summary

journal-article

Exposure-Response Analysis for Efficacy of Daclatasvir, Asunaprevir, and Beclabuvir Combinations in HCV-Infected Patients.

Jan 2019

Published by

Clinical pharmacology in drug development

Summary

journal-article